<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Because MYC plays a causal role in many human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including those with hypoxic and nutrient-poor <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironments, we have determined the metabolic responses of a MYC-inducible human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> model P493 cell line to aerobic and hypoxic conditions, and to <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, using stable isotope-resolved metabolomics </plain></SENT>
<SENT sid="1" pm="."><plain>Using [U-(13)C]-<z:chebi fb="105" ids="17234">glucose</z:chebi> as the tracer, both <z:chebi fb="105" ids="17234">glucose</z:chebi> consumption and <z:chebi fb="4" ids="24996">lactate</z:chebi> production were increased by MYC expression and <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Using [U-(13)C,(15)N]-glutamine as the tracer, glutamine import and metabolism through the <z:chebi fb="6" ids="30956">TCA</z:chebi> cycle persisted under <z:mp ids='MP_0005039'>hypoxia</z:mp>, and glutamine contributed significantly to <z:chebi fb="2" ids="50744">citrate</z:chebi> carbons </plain></SENT>
<SENT sid="3" pm="."><plain>Under <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation, glutamine-derived fumarate, malate, and <z:chebi fb="2" ids="50744">citrate</z:chebi> were significantly increased </plain></SENT>
<SENT sid="4" pm="."><plain>Their (13)C-labeling patterns demonstrate an alternative energy-generating glutaminolysis pathway involving a <z:chebi fb="105" ids="17234">glucose</z:chebi>-independent <z:chebi fb="6" ids="30956">TCA</z:chebi> cycle </plain></SENT>
<SENT sid="5" pm="."><plain>The essential role of glutamine metabolism in cell survival and proliferation under <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:chebi fb="105" ids="17234">glucose</z:chebi> deficiency makes them susceptible to the glutaminase inhibitor BPTES and hence could be targeted for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
</text></document>